Abstract
Bacterial meningitis is a serious problem in pediatric clinics and, therefore, needs urgent and empirical chemotherapy. We investigated 1,116 cases of empirical chemotherapy of patients aged older than 4 months from 1997 through 2008 by sending questionnaires. A single antibiotic treatment was carried out in less than 30% of the cases throughout the years, whereas the combination of two antibiotics had been practiced in more than 70% of the cases. The main antibiotics used were cephalosporins, carbapenems, and ampicillin. Combinatory use of ampicillin and cephalosporin was carried out in 74.7–82.7% of cases in 1997–2000, but sharply declined thereafter to 0–13.8% in 2004–2008. However, the combination of carbapenem and cephalosporin compensated for the decline, increasing from 3.8–6.6% in 1998–1999 to 79.5–89.9% in 2005–2008. The breakdown in the use of cephalosporins, carbapenems, and ampicillin in two-drug combinatory therapy was as follows. (i) Use of cefotaxime was 61.8–75.3% in 1997–2001, but decreased to nearly 50%, equivalent to the level of ceftriaxone use in 2003–2008. (ii) Use of ampicillin dropped from 74.7–92.3% in 1997–2000 to 4.6% in 2008, and this decreased level was compensated for by the use of carbapenems. Overall, combinatory chemotherapy of the third-generation cephalosporins and carbapenems seems to be practical. The discussion in this report includes the difference between Japan and the United States in the prevalence of the causative agents and the use of antibiotics. These studies provide information on trends in the treatment of children’s meningitis in Japan and will be useful for the design of future empirical chemotherapy.
Similar content being viewed by others
References
Schoendorf K, Adams W, Kiely J, Wegener J. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics. 1994;93:663–8.
Schlech WF, Ward J, Band J, Hightower A, Fraser D, Broome C. Bacterial meningitis in the United States, 1978 through 1981. The National Meningitis Surveillance Study. JAMA. 1985;253:1749–54.
Saez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003;361:2139–48.
Sunakawa K, Nonoyama M, Oishi T, Iwata S, Akita H, Satoh Y, et al. Trends in pediatric bacterial meningitis in Japan (2000–2002). Kansenshogaku Zasshi. 2004;78:879–89.
Sunakawa K, Nonoyama M, Oishi T, Iwata S, Akita H, Satoh Y, et al. Trends in pediatric bacterial meningitis in Japan (2003–2004). Kansenshogaku Zasshi. 2006;80:27–38.
Sunakawa K, Nonoyama M, Takayama Y, Yamaguti Y, Oishi T, Iwata S, et al. The trend of childhood bacterial meningitis in Japan (1997. 7–2000. 6). Kansenshogaku Zasshi. 2001;75:931–9.
Sunakawa K, Ubukata K, Chiba N, Hasegawa K, Nonoyama M, Iwata S, et al. Childhood bacterial meningitis trends in Japan from 2005 to 2006. Kansenshogaku Zasshi. 2008;82:187–97.
Schuchat A, Robinson K, Wenger J, Harrison L, Farley M, Reingold A, et al. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337:970–6.
Itoyama Y, Kamei S, Hosoya M, Shiga Y, Sato S, Ishikawa H, et al. Clinical guideline of bacterial meningitis. Neurol Therapeut. 2007;24:71–132.
Ubukata K, Chiba N, Hasegawa K, Kobayashi R, Iwata S, Sunakawa K. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1992 to 2002. Antimicrob Agents Chemother. 2004;48:1488–94.
McCullers JA, English BK, Novak R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis. 2000;181:369–73.
Novak R, Henriques B, Charpentier E, Normark S, Tuomanen EI. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature (Lond). 1999;399:590–3.
Rodriguez CA, Atkinson R, Bitar W, Whitney CG, Edwards KM, Mitchell L, et al. Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. J Infect Dis. 2004;190:1484–7.
Acknowledgments
The authors are grateful to the doctors and staff of the pediatric department who responded to the questionnaires.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sakai, F., Hanaki, H., Ikeda-Dantsuji, Y. et al. Trends in empirical chemotherapy of bacterial meningitis in children aged more than 4 months in Japan: a survey from 1997 through 2008. J Infect Chemother 17, 358–362 (2011). https://doi.org/10.1007/s10156-010-0126-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-010-0126-9